Speakers at the workshop focused on discussing three main topics: the role, challenges and prospects of vaccination for pregnant women in preventing infectious diseases in young children; maternal immunotherapy to prevent respiratory viral inflammatory syndrome (RSV) in infants; and optimizing community protection against RSV.
According to experts, pregnant women have physiological and immune changes, causing a higher risk of infectious diseases, affecting the health of mothers, fetuses and newborns. Meanwhile, in the first months of life, children are susceptible to diseases because their immune system is not yet complete, and direct vaccination is ineffective.
During this period, children rely primarily on passive antibodies from their mother. Therefore, creating immunity for pregnant women becomes an important solution, helping to transmit antibodies to protect children right from birth, reducing the risk of serious diseases.
